JG
RCKT icon

Jefferies Group’s Rocket Pharmaceuticals RCKT Stock Holding History

Jefferies Group’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1.6M Buy
+100,000
New +$1.56M 0.01% 677
2021
Q4 		– Sell
-9,400
Closed -$281K – 1932
2021
Q3 		$281K Hold
9,400
– – ﹤0.01% 1379
2021
Q2 		$416K Buy
+9,400
New +$408K ﹤0.01% 1222

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jefferies Group's RCKT Position: Q3 2022 in Review

Jefferies Group opened a new position in Rocket Pharmaceuticals (RCKT) in Q3 2022: 22,500 shares worth $359K. The stake represents ﹤0.01% of the portfolio and ranks #1163 among its holdings. This is a return to the name: Jefferies Group previously reported a position in RCKT as recently as Q3 2021.

Jefferies Group first reported a position in RCKT in Q4 2019 and has held it in 4 quarters since. The position peaked at $1.92M in Q4 2020. 164 funds tracked by Wall St. Rank hold RCKT as of Q3 2022.

  • Jefferies Group held 22,500 shares of Rocket Pharmaceuticals worth $359K as of Q3 2022.
  • Rocket Pharmaceuticals was a new Jefferies Group position in Q3 2022.
  • Rocket Pharmaceuticals made up ﹤0.01% of Jefferies Group's portfolio in Q3 2022, its #1163 holding.
  • Jefferies Group first reported a position in Rocket Pharmaceuticals in Q4 2019 and has held it in 4 quarters since.
  • Jefferies Group's Rocket Pharmaceuticals position peaked at $1.92M in Q4 2020.
  • 164 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.